Fortune January 11, 2025
Lindsey Leake

“Stomach bug,” “cruise-ship virus,” “winter vomiting disease”—all are nicknames for norovirus, the top cause of vomiting, diarrhea, and foodborne illness in the U.S. The contagious ailment typically circulates throughout the late fall, winter, and early spring, and the 2024–25 season is no exception. Nationwide test positivity was nearly 23% the week ended Dec. 28, compared to less than 11% six weeks earlier, according to the Centers for Disease Control and Prevention (CDC).

Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says. Though most people recover from the gastrointestinal illness within three days, norovirus is annually responsible for 465,000 emergency department visits, mostly in young children; 109,000 hospitalizations; and 900...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Pharma / Biotech, Public Health / COVID
Report: Prices for top Medicare Part D drugs nearly doubled since entering the market
High cost of weight loss drugs drives employers to require nutrition counseling, in boost for startups
Announcement: Andreessen Horowitz Partners with Lilly to Launch First-of-Its-Kind Biotech Ecosystem Fund
Boosting biopharma R&D performance with a next-generation technology stack
Charting the path to patients

Share This Article